Deciding on the therapy of multiple myeloma using genetic risk stratification.
Department of Hematology, Mayo Clinic, Rochester, MN 55905, USA. gertz.morie@mayo.edu
Morie A
MA
Gertz
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D014178:Translocation, Genetic / Q000235:genetics*
D000970:Antineoplastic Agents